Molecular Psychiatry

The book highlights important aspects of Molecular Psychiatry, including molecular mechanisms, animal models, biomarkers, advanced methods, drugs and antidepressant response, as well as genetics and epigenetics. Molecular mechanisms are a vital part of the search for the biological basis of psychiat...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (288 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 06054nam-a2201705z--4500
001 993546310304498
005 20231214133638.0
006 m o d
007 cr|mn|---annan
008 202105s2020 xx |||||o ||| 0|eng d
035 |a (CKB)5400000000045453 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/68695 
035 |a (EXLCZ)995400000000045453 
041 0 |a eng 
100 1 |a Rein, Theo  |4 edt 
245 1 0 |a Molecular Psychiatry 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (288 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a The book highlights important aspects of Molecular Psychiatry, including molecular mechanisms, animal models, biomarkers, advanced methods, drugs and antidepressant response, as well as genetics and epigenetics. Molecular mechanisms are a vital part of the search for the biological basis of psychiatric disorders, providing molecular hints that can later be tested as biomarkers or targets for drug development. Animal models represent a commonly used approach to aid in this bench-to-bed translation; the examples here are social defeat stress and the Roman High-Avoidance (RHA) and the Roman Low-Avoidance (RLA) rats. For biomarkers, psychiatric disorders pose a particular challenge due to the tissue specificity of many currently investigated biomarkers; i.e., not all blood-based measures directly represent changes in the brain. The Ebook includes five articles focused on the challenges of identifying clinically and biologically relevant biomarkers for psychiatric disorders. Scientific progress typically is fostered by the development of new methods. The application of machine learning methods for the proper analysis of Big Data and induced pluripotent stem cells are examples outlined in this Ebook. Furthermore, three articles are devoted to the understanding of the mechanisms of actions of existing drugs with the ultimate goal of identifying ways to predict treatment response in patients. Finally, three articles deepen the insight into the genetics and epigenetics of psychiatric disorders. 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Mental health services  |2 bicssc 
653 |a cardiovascular disease 
653 |a cell adhesion molecules 
653 |a immunology 
653 |a inflammation 
653 |a nervous system 
653 |a schizophrenia 
653 |a bipolar disorder 
653 |a major depressive disorder 
653 |a DNA methylation 
653 |a response variability 
653 |a antipsychotics 
653 |a drug design 
653 |a multi-target drugs 
653 |a polypharmacology 
653 |a multi-task learning 
653 |a machine learning 
653 |a biomarker discovery 
653 |a psychiatry 
653 |a serotonin 
653 |a 5-HT 4 receptor 
653 |a 5-HT4R 
653 |a depression 
653 |a mood disorder 
653 |a expression 
653 |a Alzheimer's disease 
653 |a cognition 
653 |a Parkinson's disease 
653 |a forced swimming 
653 |a Roman rat lines 
653 |a stress 
653 |a hippocampus 
653 |a BDNF 
653 |a trkB 
653 |a PSA-NCAM 
653 |a western blot 
653 |a immunohistochemistry 
653 |a general cognitive function 
653 |a intelligence 
653 |a GWAS 
653 |a genetic correlation 
653 |a childhood-onset schizophrenia (COS) 
653 |a induced pluripotent stem cell (iPSC) 
653 |a copy number variation (CNV) 
653 |a early neurodevelopment 
653 |a neuronal differentiation 
653 |a synapse 
653 |a dendritic arborization 
653 |a miRNAs 
653 |a stress physiology 
653 |a cytoskeleton 
653 |a actin dynamics 
653 |a DRR1 
653 |a TU3A 
653 |a FAM107A 
653 |a acid sphingomyelinase 
653 |a alcohol dependence 
653 |a liver enzymes 
653 |a sphingolipid metabolism 
653 |a withdrawal 
653 |a Hsp90 
653 |a GR 
653 |a stress response 
653 |a steroid hormones 
653 |a molecular chaperones 
653 |a psychiatric disease 
653 |a circadian rhythms 
653 |a FKBP51 
653 |a FKBP52 
653 |a CyP40 
653 |a PP5 
653 |a DISC1 
653 |a neurodevelopment 
653 |a CRMP-2 
653 |a proteomics 
653 |a antidepressant treatment 
653 |a HPA axis 
653 |a gene expression 
653 |a FKBP5 
653 |a sleep 
653 |a sleep EEG 
653 |a biomarkers 
653 |a antidepressants 
653 |a cordance 
653 |a gender 
653 |a sex difference 
653 |a antidepressant 
653 |a rapid-acting 
653 |a Ketamine 
653 |a endocrinology 
653 |a (2R,6R)-Hydroxynorketamine 
653 |a electroconvulsive therapy 
653 |a basic-helix-loop-helix 
653 |a brain 
653 |a coactivator 
653 |a glucocorticoids 
653 |a mineralocorticoid receptor knockout 
653 |a transcription biology 
653 |a dopaminergic gene polymorphisms 
653 |a affective temperament 
653 |a obesity 
653 |a alpha-synuclein 
653 |a SNCA 
653 |a major depression 
653 |a Hamilton Scale of Depression 
653 |a chemokines 
653 |a neuroinflammation 
653 |a social defeat 
653 |a Immune response 
653 |a T cells 
653 |a susceptibility 
653 |a resilience 
653 |a Treg cells 
653 |a Th17 cells 
653 |a behavior 
653 |a PPARγ 
776 |z 3-03936-120-1 
776 |z 3-03936-121-X 
700 1 |a Fries, Gabriel R.  |4 edt 
700 1 |a Rein, Theo  |4 oth 
700 1 |a Fries, Gabriel R.  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 06:01:15 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338165650004498&Force_direct=true  |Z 5338165650004498  |b Available  |8 5338165650004498